SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 203 filers reported holding SEATTLE GENETICS INC in Q1 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,516,000 | +15.1% | 23,078 | -0.1% | 0.02% | +9.1% |
Q2 2020 | $3,925,000 | +92.0% | 23,099 | +30.4% | 0.02% | +57.1% |
Q1 2020 | $2,044,000 | +10.5% | 17,713 | +9.4% | 0.01% | +40.0% |
Q4 2019 | $1,850,000 | +33.8% | 16,194 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $1,383,000 | +23.4% | 16,194 | 0.0% | 0.01% | +14.3% |
Q2 2019 | $1,121,000 | -5.5% | 16,194 | 0.0% | 0.01% | -12.5% |
Q1 2019 | $1,186,000 | +3.9% | 16,194 | -19.6% | 0.01% | 0.0% |
Q4 2018 | $1,142,000 | -26.5% | 20,150 | +0.0% | 0.01% | -11.1% |
Q3 2018 | $1,554,000 | +16.1% | 20,148 | -0.1% | 0.01% | 0.0% |
Q2 2018 | $1,339,000 | +26.8% | 20,168 | -0.1% | 0.01% | +28.6% |
Q1 2018 | $1,056,000 | -5.9% | 20,183 | -3.8% | 0.01% | 0.0% |
Q4 2017 | $1,122,000 | +1.3% | 20,979 | +3.0% | 0.01% | -12.5% |
Q3 2017 | $1,108,000 | +5.1% | 20,370 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $1,054,000 | -17.8% | 20,370 | -0.2% | 0.01% | -20.0% |
Q1 2017 | $1,283,000 | +14.1% | 20,411 | -4.2% | 0.01% | +11.1% |
Q4 2016 | $1,124,000 | -9.9% | 21,305 | -7.7% | 0.01% | -10.0% |
Q3 2016 | $1,247,000 | +24.3% | 23,089 | -7.0% | 0.01% | +25.0% |
Q2 2016 | $1,003,000 | +5.0% | 24,830 | -8.8% | 0.01% | 0.0% |
Q1 2016 | $955,000 | -21.8% | 27,228 | -0.0% | 0.01% | -20.0% |
Q4 2015 | $1,222,000 | +18.0% | 27,234 | +1.4% | 0.01% | +11.1% |
Q3 2015 | $1,036,000 | -20.4% | 26,867 | -0.1% | 0.01% | -18.2% |
Q2 2015 | $1,302,000 | +19.8% | 26,900 | -12.5% | 0.01% | +22.2% |
Q1 2015 | $1,087,000 | +10.4% | 30,747 | +0.3% | 0.01% | +12.5% |
Q4 2014 | $985,000 | -13.7% | 30,666 | -0.2% | 0.01% | -20.0% |
Q3 2014 | $1,142,000 | -9.6% | 30,721 | -6.9% | 0.01% | -9.1% |
Q2 2014 | $1,263,000 | -16.1% | 33,011 | -0.1% | 0.01% | -15.4% |
Q1 2014 | $1,505,000 | +14.2% | 33,029 | -0.0% | 0.01% | +18.2% |
Q4 2013 | $1,318,000 | -8.9% | 33,041 | +0.2% | 0.01% | -15.4% |
Q3 2013 | $1,446,000 | +54.8% | 32,984 | +11.1% | 0.01% | +44.4% |
Q2 2013 | $934,000 | – | 29,691 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |